Transcriptome‑wide piRNA profiling in human gastric cancer
Piwi‑interacting RNAs (piRNAs) comprise the largest class of non‑coding RNAs. They represent a molecular feature shared by all non‑aging biological systems, including germline and somatic cancer stem cells, which display an indefinite capacity of renewal and proliferation and are potentially immorta...
Saved in:
Published in | Oncology reports Vol. 41; no. 5; pp. 3089 - 3099 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
Spandidos Publications
01.05.2019
Spandidos Publications UK Ltd D.A. Spandidos |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Piwi‑interacting RNAs (piRNAs) comprise the largest class of non‑coding RNAs. They represent a molecular feature shared by all non‑aging biological systems, including germline and somatic cancer stem cells, which display an indefinite capacity of renewal and proliferation and are potentially immortal. They have been identified in animal stomachs, but their relationship with human gastric cancers remains largely unclear. The present study aimed to identify the piRNAs associated with human gastric cancers across the whole transcriptome. Fresh tumor tissues and adjacent non‑tumorous tissues from stomachs were examined using a piRNA microarray (23,677 piRNAs) that was then validated by qPCR. The differential expression of piRNAs between cases and controls was analyzed. The transposable elements (TEs) that are potentially targeted by the risk piRNAs were searched. The expression of the nearest genes that are complementary to the sequences of the piRNAs was examined in the stomach tissue. The regulatory effects of genome‑wide significant and replicated cancer‑risk DNA variants on the piRNA expression in stomach were tested. Based on the findings, we identified a total of 8,759 piRNAs in human stomachs. Of all, 50 were significantly (P<0.05) and differentially (>2‑fold change) expressed between the cases and controls, and 64.7% of the protein‑coding genes potentially regulated by the gastric cancer‑associated piRNAs were expressed in the human stomach. The expression of many cancer‑associated piRNAs was correlated with the genome‑wide and replicated cancer‑risk SNPs. In conclusion, we conclude that piRNAs are abundant in human stomachs and may play important roles in the etiological processes of gastric cancers. |
---|---|
AbstractList | Piwi-interacting RNAs (piRNAs) comprise the largest class of non-coding RNAs. They represent a molecular feature shared by all non-aging biological systems, including germline and somatic cancer stem cells, which display an indefinite capacity of renewal and proliferation and are potentially immortal. They have been identified in animal stomachs, but their relationship with human gastric cancers remains largely unclear. The present study aimed to identify the piRNAs associated with human gastric cancers across the whole transcriptome. Fresh tumor tissues and adjacent non-tumorous tissues from stomachs were examined using a piRNA microarray (23,677 piRNAs) that was then validated by qPCR. The differential expression of piRNAs between cases and controls was analyzed. The transposable elements (TEs) that are potentially targeted by the risk piRNAs were searched. The expression of the nearest genes that are complementary to the sequences of the piRNAs was examined in the stomach tissue. The regulatory effects of genome-wide significant and replicated cancer-risk DNA variants on the piRNA expression in stomach were tested. Based on the findings, we identified a total of 8,759 piRNAs in human stomachs. Of all, 50 were significantly (P<0.05) and differentially (>2-fold change) expressed between the cases and controls, and 64.7% of the protein-coding genes potentially regulated by the gastric cancer-associated piRNAs were expressed in the human stomach. The expression of many cancer-associated piRNAs was correlated with the genome-wide and replicated cancer-risk SNPs. In conclusion, we conclude that piRNAs are abundant in human stomachs and may play important roles in the etiological processes of gastric cancers. Piwi‑interacting RNAs (piRNAs) comprise the largest class of non‑coding RNAs. They represent a molecular feature shared by all non‑aging biological systems, including germline and somatic cancer stem cells, which display an indefinite capacity of renewal and proliferation and are potentially immortal. They have been identified in animal stomachs, but their relationship with human gastric cancers remains largely unclear. The present study aimed to identify the piRNAs associated with human gastric cancers across the whole transcriptome. Fresh tumor tissues and adjacent non‑tumorous tissues from stomachs were examined using a piRNA microarray (23,677 piRNAs) that was then validated by qPCR. The differential expression of piRNAs between cases and controls was analyzed. The transposable elements (TEs) that are potentially targeted by the risk piRNAs were searched. The expression of the nearest genes that are complementary to the sequences of the piRNAs was examined in the stomach tissue. The regulatory effects of genome‑wide significant and replicated cancer‑risk DNA variants on the piRNA expression in stomach were tested. Based on the findings, we identified a total of 8,759 piRNAs in human stomachs. Of all, 50 were significantly (P<0.05) and differentially (>2‑fold change) expressed between the cases and controls, and 64.7% of the protein‑coding genes potentially regulated by the gastric cancer‑associated piRNAs were expressed in the human stomach. The expression of many cancer‑associated piRNAs was correlated with the genome‑wide and replicated cancer‑risk SNPs. In conclusion, we conclude that piRNAs are abundant in human stomachs and may play important roles in the etiological processes of gastric cancers.Piwi‑interacting RNAs (piRNAs) comprise the largest class of non‑coding RNAs. They represent a molecular feature shared by all non‑aging biological systems, including germline and somatic cancer stem cells, which display an indefinite capacity of renewal and proliferation and are potentially immortal. They have been identified in animal stomachs, but their relationship with human gastric cancers remains largely unclear. The present study aimed to identify the piRNAs associated with human gastric cancers across the whole transcriptome. Fresh tumor tissues and adjacent non‑tumorous tissues from stomachs were examined using a piRNA microarray (23,677 piRNAs) that was then validated by qPCR. The differential expression of piRNAs between cases and controls was analyzed. The transposable elements (TEs) that are potentially targeted by the risk piRNAs were searched. The expression of the nearest genes that are complementary to the sequences of the piRNAs was examined in the stomach tissue. The regulatory effects of genome‑wide significant and replicated cancer‑risk DNA variants on the piRNA expression in stomach were tested. Based on the findings, we identified a total of 8,759 piRNAs in human stomachs. Of all, 50 were significantly (P<0.05) and differentially (>2‑fold change) expressed between the cases and controls, and 64.7% of the protein‑coding genes potentially regulated by the gastric cancer‑associated piRNAs were expressed in the human stomach. The expression of many cancer‑associated piRNAs was correlated with the genome‑wide and replicated cancer‑risk SNPs. In conclusion, we conclude that piRNAs are abundant in human stomachs and may play important roles in the etiological processes of gastric cancers. |
Audience | Academic |
Author | Shi, Yi Zhang, Hejun Zheng, Jianming Liu, Fen Sun, Tao Lin, Xiandong Mao, Qiao Zhang, Huihao Chao, Herta Hu, Dan Xu, Jianying Yu, Zongyang Xia, Yan Chen, Gang Li, Chao Zheng, Xiongwei Zhu, Weifeng Luο, Xingguang |
AuthorAffiliation | 8 Huashan Hospital, Fudan University School of Medicine, Shanghai 200040, P.R. China 11 Cancer Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA 13 Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA 1 Laboratory of Radiation Oncology and Radiobiology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China 6 Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350002, P.R. China 12 Huilongguan Hospital, Beijing University School of Clinical Medicine, Beijing 100096, P.R. China 2 Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, P.R. China 7 The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China 9 Zhuhai Municipal Maternal and Children's Health Hospital, Zhuhai, Guangdong 519000, P.R. China 10 Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA 4 People's Hospital of D |
AuthorAffiliation_xml | – name: 4 People's Hospital of Deyang City, Deyang, Sichun 618000, P.R. China – name: 5 Department of Medical Oncology, Fuzhou General Hospital of PLA, Fuzhou, Fujian 350025, P.R. China – name: 6 Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350002, P.R. China – name: 2 Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, P.R. China – name: 1 Laboratory of Radiation Oncology and Radiobiology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – name: 7 The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China – name: 9 Zhuhai Municipal Maternal and Children's Health Hospital, Zhuhai, Guangdong 519000, P.R. China – name: 13 Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA – name: 10 Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA – name: 11 Cancer Center, VA Connecticut Healthcare System, West Haven, CT 06516, USA – name: 8 Huashan Hospital, Fudan University School of Medicine, Shanghai 200040, P.R. China – name: 3 Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – name: 12 Huilongguan Hospital, Beijing University School of Clinical Medicine, Beijing 100096, P.R. China |
Author_xml | – sequence: 1 givenname: Xiandong surname: Lin fullname: Lin, Xiandong organization: Laboratory of Radiation Oncology and Radiobiology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 2 givenname: Yan surname: Xia fullname: Xia, Yan organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 3 givenname: Dan surname: Hu fullname: Hu, Dan organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 4 givenname: Qiao surname: Mao fullname: Mao, Qiao organization: People's Hospital of Deyang City, Deyang, Sichun 618000, P.R. China – sequence: 5 givenname: Zongyang surname: Yu fullname: Yu, Zongyang organization: Department of Medical Oncology, Fuzhou General Hospital of PLA, Fuzhou, Fujian 350025, P.R. China – sequence: 6 givenname: Hejun surname: Zhang fullname: Zhang, Hejun organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 7 givenname: Chao surname: Li fullname: Li, Chao organization: Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, P.R. China – sequence: 8 givenname: Gang surname: Chen fullname: Chen, Gang organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 9 givenname: Fen surname: Liu fullname: Liu, Fen organization: Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350002, P.R. China – sequence: 10 givenname: Weifeng surname: Zhu fullname: Zhu, Weifeng organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 11 givenname: Yi surname: Shi fullname: Shi, Yi organization: Department of Pathology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, P.R. China – sequence: 12 givenname: Huihao surname: Zhang fullname: Zhang, Huihao organization: The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China – sequence: 13 givenname: Jianming surname: Zheng fullname: Zheng, Jianming organization: Huashan Hospital, Fudan University School of Medicine, Shanghai 200040, P.R. China – sequence: 14 givenname: Tao surname: Sun fullname: Sun, Tao organization: Huashan Hospital, Fudan University School of Medicine, Shanghai 200040, P.R. China – sequence: 15 givenname: Jianying surname: Xu fullname: Xu, Jianying organization: Zhuhai Municipal Maternal and Children's Health Hospital, Zhuhai, Guangdong 519000, P.R. China – sequence: 16 givenname: Herta surname: Chao fullname: Chao, Herta organization: Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, P.R. China – sequence: 17 givenname: Xiongwei surname: Zheng fullname: Zheng, Xiongwei organization: Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian 350014, P.R. China – sequence: 18 givenname: Xingguang surname: Luο fullname: Luο, Xingguang organization: Huilongguan Hospital, Beijing University School of Clinical Medicine, Beijing 100096, P.R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30896887$$D View this record in MEDLINE/PubMed |
BookMark | eNptkktrFTEUx4NU7EN3rmVAEBfONY_JC4pwKb6gKMhduAuZTObelEwyJjNKd_0KfkU_iRlaa28pWSRwfud_Tv7nHIODEIMF4DmCKyIkfhvTCkMkVxxy8ggcIS5RjRuCDsobYlQTQr8fguOcLyDEHDL5BBwSKCQTgh-B003SIZvkxikO9s_V71-us9Xovn1ZV2OKvfMubCsXqt086FBtdZ6SM5XRwdj0FDzutc_22c19AjYf3m_OPtXnXz9-Pluf14ZyNtXCNAZRYyxkuqOyhxS1spMUa8yxlqxrYYcwlx0zSPO2MS0xhHPBG4m6hpET8O5adpzbwXbGhilpr8bkBp0uVdRO7UeC26lt_KlY04jiQRF4fSOQ4o_Z5kkNLhvrvQ42zllhVJrhiAle0Jf30Is4p1B-pzAu_gmEEftPbbW3yoU-lrpmEVVrKgiTlDakUKsHqHI6OzhTpljctfsJr-4k7Kz20y5HP08uhrwPvrjryK0V_-ZagDfXgEkx52T7WwRBtayNikkta6OWtSk4vocbN-mlbOnY-YeT_gIPjsOl |
CitedBy_id | crossref_primary_10_3389_fgene_2022_1069637 crossref_primary_10_3390_ijms21207656 crossref_primary_10_1021_acs_analchem_9b03819 crossref_primary_10_1007_s10555_020_09863_0 crossref_primary_10_1007_s00210_024_03308_z crossref_primary_10_3389_fmolb_2022_848105 crossref_primary_10_3389_fimmu_2023_1175924 crossref_primary_10_3389_fonc_2023_1203821 crossref_primary_10_1007_s10555_020_09925_3 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2019 Copyright © 2019, Spandidos Publications 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2019 – notice: Copyright © 2019, Spandidos Publications 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.3892/or.2019.7073 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database (Proquest) ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) British Nursing Index with Full Text ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-2431 |
EndPage | 3099 |
ExternalDocumentID | PMC6448102 A583695543 30896887 10_3892_or_2019_7073 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 2WC 53G 7X7 88E 8FI 8FJ AAYXX ABJNI ABUWG ACGFS ADBBV AEGXH AENEX AFKRA AFOSN AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBD EBS EJD EMOBN F5P FYUFA GX1 H13 HMCUK HUR HZ~ IAO IHR IHW INH INR IPNFZ ITC M1P O9- OK1 OVD PHGZM PHGZT PQQKQ PROAC PSQYO RIG SV3 TEORI TR2 UKHRP 123 ABPMR CGR CUY CVF ECM EIF NPM ODZKP OGEVE PJZUB PPXIY UDS PMFND 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c576t-8c4c15cce06ad59f051b9d952a272a96db0d1279d6c1a7b4cb3c37787491d463 |
IEDL.DBID | 7X7 |
ISSN | 1021-335X 1791-2431 |
IngestDate | Thu Aug 21 14:04:37 EDT 2025 Fri Jul 11 09:08:11 EDT 2025 Fri Jul 25 04:53:51 EDT 2025 Tue Jun 17 21:30:37 EDT 2025 Tue Jun 10 20:45:55 EDT 2025 Thu May 22 21:25:09 EDT 2025 Mon Jul 21 06:07:32 EDT 2025 Tue Jul 01 02:35:53 EDT 2025 Thu Apr 24 23:09:10 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c576t-8c4c15cce06ad59f051b9d952a272a96db0d1279d6c1a7b4cb3c37787491d463 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Contributed equally |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC6448102 |
PMID | 30896887 |
PQID | 2202781216 |
PQPubID | 2044953 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6448102 proquest_miscellaneous_2195271687 proquest_journals_2202781216 gale_infotracmisc_A583695543 gale_infotracacademiconefile_A583695543 gale_healthsolutions_A583695543 pubmed_primary_30896887 crossref_primary_10_3892_or_2019_7073 crossref_citationtrail_10_3892_or_2019_7073 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-05-01 |
PublicationDateYYYYMMDD | 2019-05-01 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Athens |
PublicationTitle | Oncology reports |
PublicationTitleAlternate | Oncol Rep |
PublicationYear | 2019 |
Publisher | Spandidos Publications Spandidos Publications UK Ltd D.A. Spandidos |
Publisher_xml | – name: Spandidos Publications – name: Spandidos Publications UK Ltd – name: D.A. Spandidos |
SSID | ssj0027069 |
Score | 2.3659256 |
Snippet | Piwi‑interacting RNAs (piRNAs) comprise the largest class of non‑coding RNAs. They represent a molecular feature shared by all non‑aging biological systems,... Piwi-interacting RNAs (piRNAs) comprise the largest class of non-coding RNAs. They represent a molecular feature shared by all non-aging biological systems,... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 3089 |
SubjectTerms | Adult Aged Aging Alzheimer's disease Animals Breast cancer Cancer Cancer research Causes of Cohort Studies Deoxyribonucleic acid DNA DNA Transposable Elements - genetics Female Gastric cancer Gene expression Gene Expression Profiling - methods Gene Expression Regulation, Neoplastic Genes Genetic aspects Genetic research Genomes Genomics Hospitals Humans Male Middle Aged Oligonucleotide Array Sequence Analysis - methods Pathogenesis Polymorphism, Single Nucleotide - genetics Protein expression Proteins RNA RNA, Small Interfering - genetics RNA, Small Interfering - metabolism Stem cells Stomach - pathology Stomach cancer Stomach Neoplasms - genetics Stomach Neoplasms - pathology Studies Transcriptome - genetics Transposons Tumors |
Title | Transcriptome‑wide piRNA profiling in human gastric cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30896887 https://www.proquest.com/docview/2202781216 https://www.proquest.com/docview/2195271687 https://pubmed.ncbi.nlm.nih.gov/PMC6448102 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEB-0BfFF_Pa01hUUHyR2N9kkG1_klJYi9JBS4d5CNknrQbt7Xq_47zuzm1tvBX3O7Nd85JfJTuYH8IZSjojAwoRzipUVD8zJumY8hBKtbJwv6XDyyUwdfy-_zuU8bbhdp7LKzZzYTdSh9bRHfsApS0c0KtSn5U9GrFH0dzVRaNyGXWpdRl6t51sJV95R2hF7NRNCzvvCd4RoftBSL9DCfNC5FiNI-nti3kKmcdXkFgwd3Yd7af2YTXuDP4BbsXkId07SH_JH8LEDn24qaK8i-7UIMVsuTmfTrGfnRqTKFk3WUfNlF45YO3zmyfSrx3B2dHj25ZglfgTmMUtYswr1WEjvY65ckOYc46s2wUjuuObOqFDnoeDaBOULp-vS18ILjRFamiKUSjyBnaZt4jPIpDiPuQx55fCeoQwmGk9MU0ZEXiPkT-D9RkPWp97hRGFxaTGHIH3admVJn5b0OYG3g_Sy75nxD7lXpGzbn_gcQs1OZSWUwXUOSrzrJCjY8HnepTMD-NbUtmokuTeSxCDx4-GNQW0K0mv7x6Um8HoYpiup8KyJ7Q3KoFtxzCkrPYGnvf2HbxJ5ZVRFI3rkGYMAte4ejzSLH10Lb8qK0S2f__-1XsBdUlZfX7kHO-vVTXyJa6B1vd85-j7sfj6cfTv9DcsHBf8 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NIcFeJn6vbLAgMfGAzBI7iWMkhCpg6tjaB1SkvlmO7UElSErXadoftf-Ru_yiQYK3PfuapOfP_u6S830ALynl8EgsTBiTsjjjjpkkzxl3LsZZVsbGdDh5PElHX-PPs2S2AdftWRgqq2z3xGqjdqWld-SHnLJ0ZKMofb_4xUg1ir6uthIaNSxO_NUlpmzn744_4vwecH70afphxBpVAWYxtl6xDO8eJdb6MDUuUWeIylw5lXDDJTcqdXnoIi6VS21kZB7bXFghEdexilycCrzsLbiNvBtSridna_ldWCnokVg2EyKZ1XX2GBHww5Jaj0bqjQyl6DHg3zywRoT9Is011ju6B9tNuBoMa3zdhw1fPIA74-aD_EN4W3FdtfOUPz27nDsfLOZfJsOgFgNHYgzmRVApAQbfDImE2MAS0paPYHoTjnsMm0VZ-B0IEnHmw8SFmcFrutgprywJWynheY4RxgBetx7StmlVTooZPzSmLORPXS41-VOTPwdw0Fkv6hYd_7DbJ2fr-oBpt7L1MMlEqjCsQotXlQWtbbyfNc0RBXxq6pLVs9zrWeKatP3hdkJ1syec6z8IHsCLbph-SXVuhS8v0CZCf2IKm8kBPKnnv_tPIsxUmtGI7CGjM6BO4f2RYv696hhOSTjC8un_H2sf7o6m41N9ejw52YUtclxd2rkHm6vlhX-G4dcqf16BPgB9w4vsN2qbQEo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7RRUK9VH2zQEsqFfVQuZvYeblSVW0LKyhlhRCV9mY5trddqSTLsgj1p_HvmMkLUqm9cfYkccbfeGaS8XwAbynlcOhYmNA6ZmHKLdNRljFubYirLLUJ6XDy0Tje_xF-m0STFbhuzsJQWWWzJ5YbtS0MfSMfcMrS0RsF8WBal0Uc744-z88ZMUjRn9aGTqOCyKH7c4Xp28Wng11c6x3OR3unX_dZzTDADMbZS5biTILIGOfH2kZyigjNpJUR1zzhWsY2823AE2ljE-gkC00mjEgQ46EMbBgLvO0DWE0oKerB6pe98fHJbbbnl3x6RJ3NhIgmVdU9xgd8UFAj0kB-SPxEdPzh317hjlvslmze8YGjx_CoDl69YYW2J7Di8qewdlT_nn8GH0vPV-5DxZljVzPrvPnsZDz0KmpwdJPeLPdKXkDvpybKEOMZwt3iOZzeh-peQC8vcrcOXiSmzo-sn2q8pw2tdNIQzZUUjmcYb_ThfaMhZerG5cSf8VthAkP6VMVCkT4V6bMPO630vGrY8Q-5bVK2qo6btnauhlEqYolBFkq8KyXI0vF5RtcHFnDW1DOrI7nVkUQLNd3hZkFVvUNcqFs89-FNO0xXUtVb7opLlAlQn5jQpkkfXlbr376T8FMZpzSSdJDRClDf8O5IPvtV9g-nlBxhufH_aW3DGhqY-n4wPtyEh6S3qs5zC3rLxaV7hbHYMntdo94Ddc92dgPbuEXl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptome-wide+piRNA+profiling+in+human+gastric+cancer&rft.jtitle=Oncology+reports&rft.au=Lin%2C+Xiandong&rft.au=Xia%2C+Yan&rft.au=Hu%2C+Dan&rft.au=Mao%2C+Qiao&rft.date=2019-05-01&rft.pub=D.A.+Spandidos&rft.issn=1021-335X&rft.eissn=1791-2431&rft.volume=41&rft.issue=5&rft.spage=3089&rft.epage=3099&rft_id=info:doi/10.3892%2For.2019.7073&rft_id=info%3Apmid%2F30896887&rft.externalDocID=PMC6448102 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1021-335X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1021-335X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1021-335X&client=summon |